In first human test, genetically modified pancreas cells injected into patient’s arm evade immune attack, produce insulin



Summary

In a groundbreaking human trial, researchers successfully injected genetically modified pancreatic cells into a patient’s arm to combat type 1 diabetes. These engineered cells, designed to evade immune system attacks, demonstrated their ability to survive and produce insulin. This early-stage study offers promising evidence that this approach can provide a functional cure for the autoimmune disease, potentially eliminating the need for lifelong insulin injections. While further research and larger trials are necessary, this marks a significant step forward in developing cell-based therapies for type 1 diabetes.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!